Los Angeles Capital Management LLC Takes $311,000 Position in Guardian Pharmacy Services, Inc. $GRDN

Los Angeles Capital Management LLC acquired a new position in Guardian Pharmacy Services, Inc. (NYSE:GRDN) in the second quarter, HoldingsChannel.com reports. The institutional investor acquired 14,615 shares of the company’s stock, valued at approximately $311,000.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in the business. Royce & Associates LP lifted its holdings in Guardian Pharmacy Services by 27.6% in the 1st quarter. Royce & Associates LP now owns 273,068 shares of the company’s stock worth $5,805,000 after purchasing an additional 59,068 shares in the last quarter. Wellington Management Group LLP lifted its holdings in shares of Guardian Pharmacy Services by 14.2% in the first quarter. Wellington Management Group LLP now owns 464,924 shares of the company’s stock worth $9,884,000 after buying an additional 57,924 shares in the last quarter. Kornitzer Capital Management Inc. KS bought a new position in shares of Guardian Pharmacy Services during the second quarter worth $1,066,000. New York State Common Retirement Fund boosted its position in shares of Guardian Pharmacy Services by 16.1% during the first quarter. New York State Common Retirement Fund now owns 323,257 shares of the company’s stock worth $6,872,000 after acquiring an additional 44,709 shares during the last quarter. Finally, Peregrine Capital Management LLC grew its stake in Guardian Pharmacy Services by 21.4% during the second quarter. Peregrine Capital Management LLC now owns 214,379 shares of the company’s stock valued at $4,568,000 after acquiring an additional 37,840 shares in the last quarter.

Analyst Ratings Changes

GRDN has been the topic of several research analyst reports. Truist Financial boosted their price target on shares of Guardian Pharmacy Services from $30.00 to $34.00 and gave the stock a “buy” rating in a research note on Friday. Oppenheimer assumed coverage on Guardian Pharmacy Services in a report on Friday, October 10th. They issued an “outperform” rating and a $30.00 target price on the stock. Weiss Ratings raised Guardian Pharmacy Services from a “sell (d+)” rating to a “hold (c)” rating in a research note on Tuesday, November 11th. Finally, Wall Street Zen upgraded Guardian Pharmacy Services from a “buy” rating to a “strong-buy” rating in a report on Monday. Three investment analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company’s stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $30.67.

Guardian Pharmacy Services Trading Down 4.6%

Shares of NYSE GRDN opened at $29.03 on Monday. Guardian Pharmacy Services, Inc. has a 12-month low of $17.78 and a 12-month high of $37.43. The firm’s 50-day moving average price is $27.04 and its 200-day moving average price is $24.10. The stock has a market capitalization of $1.84 billion, a price-to-earnings ratio of 46.08 and a beta of 0.96.

Guardian Pharmacy Services (NYSE:GRDN) last issued its quarterly earnings data on Monday, November 10th. The company reported $0.25 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.24 by $0.01. The business had revenue of $377.43 million for the quarter, compared to the consensus estimate of $381.16 million. Guardian Pharmacy Services had a return on equity of 30.29% and a net margin of 2.90%. Guardian Pharmacy Services has set its FY 2025 guidance at EPS. On average, equities analysts predict that Guardian Pharmacy Services, Inc. will post 0.87 EPS for the current fiscal year.

Guardian Pharmacy Services Company Profile

Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes.